Categories: NewsPharmaceutical

PSG Biotech Launches New Integral Display Transmitter

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SumoFlo CELE-8103-D Integral Display Transmitter offers reliable and instantaneous process metrics

DOWNERS GROVE, Ill., July 24, 2024 /PRNewswire/ — PSG Biotech, part of PSG and Dover (NYSE: DOV) and a leading provider of pump and flow meter technologies for use in life science and biopharmaceutical process applications, today announced the release of the new SumoFlo® CELE-8103-D Integral Display Transmitter for its patented single-use Coriolis flow sensors.

The SumoFlo CELE-8103-D is a smart device featuring a four-line display. When paired with a flow sensor, it provides a digital readout of various measurements during the transfer of fluids through a pipeline. This allows technicians to easily and reliably monitor key process metrics, such as flow rate, totalized flow, temperature and product density, in real time. The new transmitter, available in panel-mounted and tabletop configurations, is designed to work with all SumoFlo CPFM-8103 Series Single-Use Coriolis Flow Sensor models from PSG Biotech.

“Clear, readily available process metrics are key for success in all pharmaceutical-processing applications,” said Jay Rajagopalan, Senior Director of Engineering and Product Management for PSG Biotech. “Our development of the SumoFlo CELE-8103-D Integral Display Transmitter is a seamless solution that easily integrates into all of our SumoFlo product range.”

The SumoFlo CELE-8013 Display Transmitter never comes into contact with fluids, making it a durable component that can be reused in future applications. The display transmitter is also designed for ease of use, with the unique capability to re-zero the flow sensor and reset the totalizer directly from the front panel. Overall, the SumoFlo CELE-8103 Integral Display Transmitter provides users with instantaneous process metrics, enabling biopharmaceutical processors to quickly identify and respond to process variations thereby improving yield and reducing downtime.

About PSG Biotech:

PSG Biotech, Oakbrook Terrace, IL, USA, is dedicated to “Caring For Every Drop” by being a leading provider of specialty flow-control solutions, including pumps, sensors and flow meters, that have been designed to safely transfer and precisely meter the most delicate life science biologics, medicines and therapeutics, all while increasing yield, throughput and speed to market. PSG Biotech is a brand of PSG, a Dover company, Oakbrook Terrace, IL, USA. You can find more information on PSG Biotech at psgdover.com/biotech.

About PSG:

PSG is the global pump, metering and dispensing-solution expert, enabling the safe and efficient transfer of critical and valuable fluids that require optimal performance and reliability in applications where it matters most. Additionally, PSG is a leading provider of flow meters designed to reduce waste and downtime while accurately measuring, monitoring and controlling the distribution of fluids. Headquartered in Oakbrook Terrace, IL, USA, PSG is comprised of several world-class brands, including Abaque®, All-Flo™, Almatec®, Blackmer®, Ebsray®, em-tec®, Griswold®, Hydro™, Malema™, Mouvex®, Neptune®, PSG® Biotech, Quantex™, Quattroflow® and Wilden®. PSG products are manufactured on three continents – North America, Europe and Asia – in state-of-the-art facilities that practice lean manufacturing and are ISO-certified. PSG is part of the Pumps & Process Solutions segment of Dover Corporation. For additional information on PSG, please visit psgdover.com. PSG: Where Innovation Flows.

About Dover:

Dover is a diversified global manufacturer and solutions provider with annual revenue of over $8 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 65 years, our team of approximately 25,000 employees takes an ownership mindset, collaborating with customers to redefine what’s possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under “DOV.” Additional information is available at dovercorporation.com.   

PSG Contact:
Christopher Walsh
(331) 277-8137
christopher.walsh@psgdover.com 

Dover Media Contact:
Adrian Sakowicz, VP, Communications
(630) 743-5039
asakowicz@dovercorp.com

Dover Investor Contact:
Jack Dickens, Senior Director, Investor Relations
(630) 743-2566
jdickens@dovercorp.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/psg-biotech-launches-new-integral-display-transmitter-302205588.html

SOURCE Dover

Staff

Recent Posts

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable…

19 hours ago

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility…

19 hours ago

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed mean weight reduction…

22 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and…

22 hours ago

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs…

22 hours ago

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits…

22 hours ago